Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Breast Cancer

  Free Subscription

Articles published in Am J Clin Oncol

Retrieve available abstracts of 32 articles:
HTML format

Single Articles

    July 2021
  1. SUSSELL J, Singh Jhuti G, Antao V, Herrera-Restrepo O, et al
    Cost-effectiveness Analysis of Ado-trastuzumab Emtansine (T-DM1) for the Adjuvant Treatment of Patients With Residual Invasive HER2+ Early Breast Cancer in the United States.
    Am J Clin Oncol. 2021;44:340-349.
    PubMed     Abstract available

    June 2021
  2. SPANHEIMER PM, Bashir A, Lorenzen AW, Beck AC, et al
    A Pilot Study of Preoperative Vandetanib on Markers of Proliferation and Apoptosis in Breast Cancer.
    Am J Clin Oncol. 2021 Jun 30. pii: 00000421-900000000-98548.
    PubMed     Abstract available

  3. HIRKO KA, Regan MM, Remolano MC, Schlossman J, et al
    Dermal Lymphatic Invasion, Survival, and Time to Recurrence or Progression in Inflammatory Breast Cancer.
    Am J Clin Oncol. 2021 Jun 21. pii: 00000421-900000000-98550.
    PubMed     Abstract available

    May 2021
  4. KIM K, Shim SR, Kim SJ
    Diagnostic Values of 8 Different Imaging Modalities for Preoperative Detection of Axillary Lymph Node Metastasis of Breast Cancer: A Bayesian Network Meta-analysis.
    Am J Clin Oncol. 2021 May 12. pii: 00000421-900000000-98566.
    PubMed     Abstract available

  5. MELHEM J, Amarin M, Odeh G, Al-Bustami N, et al
    Intercostobrachial Nerve (ICBN) Preservation Versus Sacrifice in Axillary Dissection: Randomized Controlled Trial.
    Am J Clin Oncol. 2021;44:206-209.
    PubMed     Abstract available

    March 2021
  6. RIZZI SKLA, Haddad CAS, Giron PS, Figueira PVG, et al
    Exercise Protocol With Limited Shoulder Range of Motion for 15 or 30 Days After Conservative Surgery for Breast Cancer With Oncoplastic Technique: A Randomized Clinical Trial.
    Am J Clin Oncol. 2021 Mar 17. pii: 00000421-900000000-98581.
    PubMed     Abstract available

    January 2021
  7. VALERIO MR, Arrivas Bajardi E, Arcara CC, Borsellino N, et al
    Eribulin Mesylate for the Treatment of Metastatic Hormone-refractory and Triple-negative Breast Cancer: A Multi-institutional Real-world Report on Efficacy and Safety.
    Am J Clin Oncol. 2021 Jan 20. pii: 00000421-900000000-98598.
    PubMed     Abstract available

    November 2020
  8. AMIN NP, Kim SM, Lasio G, Zhou J, et al
    Incidental Coronary Artery Calcium on Breast Radiation Therapy Planning Scans Identifies Patients for Cardiac Preventive Therapy.
    Am J Clin Oncol. 2020;43:826-831.
    PubMed     Abstract available

  9. GUTKIN PM, Ganjoo KN, Lohman M, von Eyben R, et al
    Angiosarcoma of the Breast: Management and Outcomes.
    Am J Clin Oncol. 2020;43:820-825.
    PubMed     Abstract available

    October 2020
  10. ZOLCSAK Z, Loirat D, Fourquet A, Kirova YM, et al
    Adjuvant Trastuzumab Emtansine (T-DM1) and Concurrent Radiotherapy for Residual Invasive HER2-positive Breast Cancer: Single-center Preliminary Results.
    Am J Clin Oncol. 2020 Oct 6. doi: 10.1097/COC.0000000000000769.
    PubMed     Abstract available

    September 2020
  11. MACARI DM, Gbadamosi B, Jaiyesimi I, Gaikazian S, et al
    Medical Cannabis in Cancer Patients: A Survey of a Community Hematology Oncology Population.
    Am J Clin Oncol. 2020;43:636-639.
    PubMed     Abstract available

    April 2020
  12. BEN KRIDIS W, Sghaier S, Charfeddine S, Toumi N, et al
    A Prospective Study About Trastuzumab-induced Cardiotoxicity in HER2-positive Breast Cancer.
    Am J Clin Oncol. 2020 Apr 16. doi: 10.1097/COC.0000000000000699.
    PubMed     Abstract available

  13. HEINEY SP, Truman S, Babatunde OA, Felder TM, et al
    Racial and Geographic Disparities in Endocrine Therapy Adherence Among Younger Breast Cancer Survivors.
    Am J Clin Oncol. 2020 Apr 3. doi: 10.1097/COC.0000000000000696.
    PubMed     Abstract available

    February 2020
  14. WENG X, Huang X, Li H, Lin S, et al
    First-Line Treatment With Atezolizumab Plus Nab-Paclitaxel for Advanced Triple-Negative Breast Cancer: A Cost-Effectiveness Analysis.
    Am J Clin Oncol. 2020 Feb 5. doi: 10.1097/COC.0000000000000671.
    PubMed     Abstract available

  15. ADDO-TABIRI NO, Chudasama R, Vasudeva R, Leiva O, et al
    Black Patients Experience Highest Rates of Cancer-associated Venous Thromboembolism.
    Am J Clin Oncol. 2020;43:94-100.
    PubMed     Abstract available

    January 2020
  16. MALEKZADEH P, Cowan K, Steinberg SM, Camphausen KA, et al
    Twenty-five-Year Follow-up of a Prospective Randomized Trial Comparing Preoperative Versus Postoperative FLAC/Granulocyte Colony-Stimulating Factor Chemotherapy for Stage II Breast Cancer.
    Am J Clin Oncol. 2020 Jan 29. doi: 10.1097/COC.0000000000000667.
    PubMed     Abstract available

    December 2019
  17. GOLD HT, Shao H, Oratz R, Yu O, et al
    Association of Diabetes and Other Clinical and Sociodemographic Factors With Guideline-concordant Breast Cancer Treatment for Breast Cancer.
    Am J Clin Oncol. 2019 Dec 16. doi: 10.1097/COC.0000000000000638.
    PubMed     Abstract available

    September 2019
  18. KIL WJ, Lee IJ, Pham T, Cho IH, et al
    Practical Heart Sparing Breast Cancer Radiation Therapy Using Continuous Positive Airway Pressure (CPAP) in Resource-Limited Radiation Oncology Clinics.
    Am J Clin Oncol. 2019 Sep 9. doi: 10.1097/COC.0000000000000597.
    PubMed     Abstract available

    June 2019
  19. LEONE JP, Leone J, Zwenger AO, Vallejo CT, et al
    Prognostic Significance of Tumor Subtypes in Women With Breast Cancer According to Stage: A Population-based Study.
    Am J Clin Oncol. 2019 Jun 3. doi: 10.1097/COC.0000000000000563.
    PubMed     Abstract available

  20. Analysis of Outcomes in Patients With BRCA1/2 Breast Cancer Mutations Treated With Accelerated Partial Breast Irradiation (APBI): Erratum.
    Am J Clin Oncol. 2019;42:545-542.

    May 2019
  21. GANDHI C, Butler E, Pesek S, Kwait R, et al
    Sexual Dysfunction in Breast Cancer Survivors: Is it Surgical Modality or Adjuvant Therapy?
    Am J Clin Oncol. 2019 May 13. doi: 10.1097/COC.0000000000000552.
    PubMed     Abstract available

    April 2019
  22. YU JB, Pollack CE, Herrin J, Zhu W, et al
    Persistent Use of Extended Fractionation Palliative Radiotherapy for Medicare Beneficiaries With Metastatic Breast Cancer, 2011 to 2014.
    Am J Clin Oncol. 2019 Apr 24. doi: 10.1097/COC.0000000000000548.
    PubMed     Abstract available

  23. AHMED F, Christos PJ, Singh P, Parashar B, et al
    Analysis of Outcomes in Patients With BRCA1/2 Breast Cancer Mutations Treated With Accelerated Partial Breast Irradiation (APBI).
    Am J Clin Oncol. 2019 Apr 9. doi: 10.1097/COC.0000000000000542.
    PubMed     Abstract available

    November 2018
  24. LEONE J, Zwenger AO, Leone BA, Vallejo CT, et al
    Overall Survival of Men and Women With Breast Cancer According to Tumor Subtype: A Population-based Study.
    Am J Clin Oncol. 2018 Nov 28. doi: 10.1097/COC.0000000000000497.
    PubMed     Abstract available

    June 2018
  25. LEONE JP, Haraldsson B, Mott SL, McDowell BD, et al
    Treatment Patterns and Survival of Elderly Patients With Breast Cancer Brain Metastases.
    Am J Clin Oncol. 2018 Jun 30. doi: 10.1097/COC.0000000000000477.
    PubMed     Abstract available

  26. GEARA FB, Eid T, Zouain N, Thebian R, et al
    Randomized, Prospective, Open-label Phase III Trial Comparing Mebo Ointment With Biafine Cream for the Management of Acute Dermatitis During Radiotherapy for Breast Cancer.
    Am J Clin Oncol. 2018 Jun 7. doi: 10.1097/COC.0000000000000460.
    PubMed     Abstract available

    May 2018
  27. ARLOW RL, Paddock LE, Niu X, Kirstein L, et al
    Breast-conservation Therapy After Neoadjuvant Chemotherapy Does Not Compromise 10-Year Breast Cancer-specific Mortality.
    Am J Clin Oncol. 2018 May 18. doi: 10.1097/COC.0000000000000456.
    PubMed     Abstract available

  28. ZAVITSANOS PJ, Wazer DE, Hepel JT, Wang Y, et al
    BRCA1 Mutations Associated With Increased Risk of Brain Metastases in Breast Cancer: A 1: 2 Matched-pair Analysis.
    Am J Clin Oncol. 2018 May 18. doi: 10.1097/COC.0000000000000466.
    PubMed     Abstract available

    February 2018
  29. CHOI SH, Chang JS, Koo JS, Park JW, et al
    Differential Prognostic Impact of Strong PD-L1 Expression and 18F-FDG Uptake in Triple-negative Breast Cancer.
    Am J Clin Oncol. 2018 Feb 6. doi: 10.1097/COC.0000000000000426.
    PubMed     Abstract available

    January 2018
  30. JEROME-D'EMILIA B, Kushary D, Burrell SA, Suplee PD, et al
    Breast Cancer Stage at Diagnosis in a New Jersey Cancer Education and Early Detection Site.
    Am J Clin Oncol. 2018 Jan 22. doi: 10.1097/COC.0000000000000425.
    PubMed     Abstract available

    December 2017
  31. SINESHAW HM, Freedman RA, DeSantis CE, Jemal A, et al
    Treatment Patterns Among Women Diagnosed With Stage I-III Triple-negative Breast Cancer.
    Am J Clin Oncol. 2017 Dec 27. doi: 10.1097/COC.0000000000000418.
    PubMed     Abstract available

    October 2017
  32. FIGUEIRA PVG, Haddad CAS, de Almeida Rizzi SKL, Facina G, et al
    Diagnosis of Axillary Web Syndrome in Patients After Breast Cancer Surgery: Epidemiology, Risk Factors, and Clinical Aspects: A Prospective Study.
    Am J Clin Oncol. 2017 Oct 17. doi: 10.1097/COC.0000000000000411.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.